🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-04-20
Trial ID
NCT05704738
Treatments Being Tested
The objective of this study is to demonstrate the efficacy of Dysport for t...
Status
Completed
Location
Peking University First Hospital
Start Date
2015-04
Trial ID
NCT02450526
Treatments Being Tested
Human recombinant interleukin-2 (rhIL-2) is a biological signalling protein...
Status
Completed
Location
Service d'Endocrinologie Pédiatrique
Start Date
2013-06-27
Trial ID
NCT01862120
Treatments Being Tested
Liraglutide is a glucose-like peptide 1 agonist, currently used as an effec...
Status
Unknown
Location
Multiple Locations
Start Date
2020-04-01
Trial ID
NCT04008290
Treatments Being Tested
In a double-blind, placebo-controlled trial, we randomly assigned 37 patien...
Status
Completed
Location
Multiple Locations
Start Date
2004-04-28
Trial ID
NCT04420481
Treatments Being Tested
Female inability to conceive a child. The purpose of this prospective rando...
Status
Completed
Location
Centrum voor Reproductieve Geneeskunde
Start Date
2019-05-01
Trial ID
NCT03677336
This study evaluated the safety and tolerability of a single dose of ALXN12...
Status
Completed
Location
Clinical Trial Site
Start Date
2016-08-19
Trial ID
NCT05288829
Treatments Being Tested
The main purpose of this study is to assess the efficacy of S-268019-b for ...
Status
Completed
Location
Buon Ma Thuot City Medical Center
Start Date
2021-12-25
Trial ID
NCT05212948
Treatments Being Tested
This was a four month dose ranging study followed by a 24 to 48 month exten...
Status
Terminated
Location
Anasazi Internal Medicine
Start Date
2009-04
Trial ID
NCT00900146
Treatments Being Tested
This pivotal, phase 3 study is designed to confirm the efficacy and safety ...
Status
Completed
Location
Wr-McCr, Llc
Start Date
2018-11-23
Trial ID
NCT03746522
Treatments Being Tested